Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure

被引：0
|
作者：
Mateo Porres-Aguilar
Oscar C. Muñoz
Aamer Abbas
机构：
[1] Texas Tech University Health Sciences Center/Paul L. Foster School of Medicine,Department of Internal Medicine
[2] Texas Tech University Health Sciences Center/Paul L. Foster School of Medicine,Division of Cardiovascular Diseases
来源：
Current Cardiology Reports | 2016年 / 18卷
关键词：
Coronary artery disease; Ivabradine; Heart failure; Heart rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Increase in heart rate represents a significant contribution in the pathophysiology of coronary artery disease and heart failure, by promoting atherosclerotic process and endothelial dysfunction. Thus, it negatively influences cardiovascular risk in the general population. The aim of this review is to analyze the current, controversial, and future role of ivabradine as an anti-anginal agent in the setting of coronary artery disease without heart failure. Ivabradine represents a selective heart rate-lowering agent that increased diastolic perfusion time and improving energetics in the ischemic myocardium.
引用
收藏
相关论文
共 50 条
  • [21] Selective and Specific Inhibition of I f with Ivabradine for the Treatment of Coronary Artery Disease or Heart Failure
    Deedwania, Prakash
    [J]. DRUGS, 2013, 73 (14) : 1569 - 1586
  • [22] Long term incidence of heart failure in stable coronary artery disease
    Sanchez, J. J.
    Ruiz Ortiz, M.
    Ogayar Luque, C.
    Romo Penas, E.
    Delgado Ortega, M.
    Mesa Rubio, D.
    Ferreiro Quero, C.
    Lopez Aguilera, J.
    Oneto, M. J.
    Paredes, N.
    Luque, A.
    Dominguez, J. C. Castillo
    Alvarez Ossorio, M. Pan
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 793 - 793
  • [23] Meta-analysis of Ivabradine in Patients With Stable Coronary Artery Disease With and Without Left Ventricular Dysfunction
    Cammarano, Carolyn
    Silva, Matthew
    Comee, Morgan
    Donovan, Jennifer L.
    Malloy, Michael J.
    [J]. CLINICAL THERAPEUTICS, 2016, 38 (02) : 387 - 395
  • [24] Selective heart rate reduction with ivabradine increases central blood pressure in stable coronary artery disease
    Cerny, D.
    Messerli, F.
    Laurent, S.
    Seiler, C.
    Rimoldi, S.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 1189 - 1189
  • [25] SELECTIVE HEART RATE REDUCTION WITH IVABRADINE INCREASES CENTRAL BLOOD PRESSURE IN STABLE CORONARY ARTERY DISEASE
    Rimoldi, S.
    Messerli, F. H.
    Cerny, D.
    Laurent, S.
    Seiler, C.
    [J]. JOURNAL OF HYPERTENSION, 2016, 34 : E6 - E6
  • [26] EFFECT OF IVABRADINE ON DIASTOLIC DYSFUNCTION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
    Gulcan, Mehmet
    Karabacak, Mustafa
    Tayyar, Senol
    Varol, Ercan
    Icli, Atilla
    Adali, Mehmet Koray
    Altinbas, Ahmet
    Uysal, Bayram Ali
    Arslan, Akif
    Bas, Hasan Aydin
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 140 : S13 - S14
  • [27] Effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease
    Traupe, T.
    Gloekler, S.
    Stoller, M.
    Steck, H.
    Khattab, A. A.
    Vogel, R.
    Seiler, C.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 567 - 567
  • [28] Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease
    Rimoldi, Stefano F.
    Messerli, Franz H.
    Cerny, David
    Gloekler, Steffen
    Traupe, Tobias
    Laurent, Stephane
    Seiler, Christian
    [J]. HYPERTENSION, 2016, 67 (06) : 1205 - 1210
  • [29] The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease
    Gloekler, Steffen
    Traupe, Tobias
    Stoller, Michael
    Schild, Deborah
    Steck, Helene
    Khattab, Ahmed
    Vogel, Rolf
    Seiler, Christian
    [J]. HEART, 2014, 100 (02) : 160 - 166
  • [30] Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure
    Sorbets, Emmanuel
    Labreuche, Julien
    Simon, Tabassome
    Delorme, Laurent
    Danchin, Nicolas
    Amarenco, Pierre
    Goto, Shinya
    Meune, Christophe
    Eagle, Kim A.
    Bhatt, Deepak L.
    Steg, Philippe Gabriel
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (26) : 1760 - 1768
12345